Magnetic resonance assessment of iron overload by separate measurement of tissue ferritin and hemosiderin iron

Annals of the New York Academy of Sciences

Volumn 1202, Issue , 2010, Pages 115-122

  Wu, Ed X ^a   Kim, Daniel ^b   Tosti, Christina L ^c   Tang, Haiying ^d   Jensen, Jens H ^b   Cheung, Jerry S ^a   Feng, Li ^e   Au, Wing Yan ^a   Ha, Shau Yin ^a   Sheth, Sujit S ^f   Brown, Truman R ^g   Brittenham, Gary M ^f  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NEW YORK UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CHONY ^*  (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

ferritin; hemosiderin; iron; magnetic resonance; magnetic susceptibility; thalassemia

Indexed keywords

FERRITIN; HEMOSIDERIN; IRON OXIDE; MANGANESE CHLORIDE;

CLINICAL ASSESSMENT; CONFERENCE PAPER; CORRELATION ANALYSIS; ELECTRON SPIN RESONANCE; HUMAN; IRON OVERLOAD; IRON STORAGE; NUCLEAR MAGNETIC RESONANCE; RADIODIAGNOSIS; THALASSEMIA MAJOR; VALIDATION STUDY;

EID: 77955885409     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05587.x     Document Type: Conference Paper

References (38)

1. Brittenham, G.M. & D.G. Badman. 2003. Noninvasive measurement of iron: report of anNIDDKworkshop. Blood 101: 15-19.
2. Jensen, P.D. 2004. Evaluation of iron overload. Br. J. Haematol. 124: 697-711.
3. Wood, J.C. 2009.History and current impact of cardiacmagnetic resonance imaging on the management of iron overload. Circulation 120: 1937-1939.
4. Arosio, P. & S. Levi. 2010. Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Biochim. Biophys. Acta [Epub ahead of print].
5. De Domenico, I., M.B. Vaughn, L. Li, et al. 2006. Ferroportin- mediatedmobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J. 25: 5396-5404.
6. De Domenico, I.,D.M.Ward & J. Kaplan. 2009. Specific iron chelators determine the route of ferritin degradation. Blood 114: 4546-4551.
7. Anderson, G.J. & C.D. Vulpe. 2009. Mammalian iron transport. Cell. Mol. Life Sci. 66: 3241-3261.
8. Breuer, W., M. Shvartsman & Z.I. Cabantchik. 2008. Intracellular labile iron. Int. J. Biochem. Cell. Biol. 40: 350-354.
9. Shi, H., K.Z. Bencze, T.L. Stemmler, et al. 2008. A cytosolic iron chaperone that delivers iron to ferritin. Science 320: 1207-1210.
10. Bovell, E., C.E. Buckley, W. Chua-anusorn, et al. 2009. Dietary iron-loaded rat liver haemosiderin and ferritin: in situ measurement of ironcorenanoparticle size andcluster structure using anomalous small-angle X-ray scattering. Phys. Med. Biol. 54: 1209-1221.
11. Chasteen, N.D. & P.M. Harrison. 1999. Mineralization in ferritin: an efficient means of iron storage. J. Struct. Biol. 126: 182-194.
12. Iancu, T.C. 1992. Ferritin and hemosiderin in pathological tissues. Electron. Microsc. Rev. 5: 209-229.
13. Iancu, T.C., Y. Deugnier, J.W. Halliday, et al. 1997. Ultrastructural sequences during liver iron overload in genetic hemochromatosis. J. Hepatol. 27: 628-638.
14. Miyazaki, E., J. Kato, M. Kobune, et al. 2002. Denatured Hferritin subunit is a major constituent of haemosiderin in the liver of patients with iron overload. Gut 50: 413-419.
15. Selden, C.,M.Owen, J.M.Hopkins, et al. 1980. Studies onthe concentration and intracellular localization of iron proteins in liver biopsy specimens from patients with iron overload with special reference to their role in lysosomal disruption. Br. J. Haematol. 44: 593-603.
16. Truty, J.,R.Malpe&M.C. Linder. 2001. Iron prevents ferritin turnover in hepatic cells. J. Biol. Chem. 276: 48775-48780.
17. Wixom, R.L., L. Prutkin&H.N.Munro. 1980.Hemosiderin: nature, formation, and significance. Int. Rev. Exp. Pathol. 22: 193-225.
18. Ghugre, N.R., T.D. Coates, M.D. Nelson, et al. 2005. Mechanisms of tissue-iron relaxivity: nuclearmagnetic resonance studies of human liver biopsy specimens.Magn. Reson.Med. 54: 1185-1193.
19. Wood, J.C., C. Enriquez, N. Ghugre, et al. 2005. Physiology and pathophysiology of iron cardiomyopathy in thalassemia. Ann. N.Y. Acad. Sci. 1054: 386-395.
20. Gossuin, Y., A. Roch, R.N. Muller, et al. 2000. Relaxation induced by ferritin and ferritin-like magnetic particles: the role of proton exchange. Magn. Reson. Med. 43: 237-243.
21. Gossuin,Y.,A.Roch,R.N.Muller, et al. 2002.Anomalousnuclearmagnetic relaxation of aqueous solutions of ferritin: an unprecedented first-order mechanism. Magn. Reson. Med. 48: 959-964.
22. Allen, P.D., T.G. St Pierre, W. Chua-anusorn, et al. 2000. Low-frequency low-field magnetic susceptibility of ferritin and hemosiderin. Biochim. Biophys. Acta 1500: 186-196.
23. Brooks, R. A., J. Vymazal, R.B. Goldfarb, et al. 1998. Relaxometry and magnetometry of ferritin. Magn. Reson. Med. 40: 227-235.
24. Jensen, J.H. & R. Chandra. 2002. Theory of nonexponential NMR signal decay in liver with iron overload or superparamagnetic iron oxide particles. Magn. Reson. Med. 47: 1131-1138.
25. Jensen, J.H., H. Tang, C.L. Tosti, et al. 2010. Separate MRI quantificaiton of dispersed (ferritin-like) and aggregated (hemosiderin-like) storage iron. Magn. Reson. Med. 63: 1201-1209.
26. Bulte, J.W., G.F. Miller, J. Vymazal, et al. 1997. Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths. Magn. Reson. Med. 37: 530-536.
27. Tang,H., J.H. Jensen, S. Sheth, et al. 2005.MRmeasurement of ferritin and hemosiderin iron in patients with iron overload. Proc. Int. Soc. Magn. Reson. Med. 13: 1880 (Abstract).
28. Thomsen, C., P. Wiggers, H. Ring-Larsen, et al. 1992. Identification of patients with hereditary haemochromatosis by magnetic resonance imaging and spectroscopic relaxation time measurements. Magn. Reson. Imaging 10: 867-879.
29. Ulmer, J.L., V.P. Mathews, C.A. Hamilton, et al. 1996. Magnetization transfer or spin-lock? An investigation of offresonance saturation pulse imaging with varying frequency offsets. AJNR Am. J. Neuroradiol. 17: 805-819.
30. Vymazal, J., O. Zak, J.W. Bulte, et al. 1996. T1 and T2 of ferritin solutions: effect of loading factor.Magn. Reson.Med. 36: 61-65.
31. Cheung, J.S., A.M. Chow, J.H. Jensen, et al. 2007. MRI characterization of iron in soluble (ferritin-like) and particulate (hemosiderin-like) mixtures. Proc. Int. Soc. Magn. Reson. Med. 15: 1153 (Abstract).
32. Wu, E.X., J.S. Cheung, A.M. Chow, et al. 2007. MRI characterization of ferritin-like and hemosiderin-like iron. Proc. Int. BioIron. Soc. 78 (Abstract).
33. Tosti, C.L., B.S. Wojczyk, S. Sheth, et al. 2010. MR iron quantification of soluble (ferritin-like) and insoluble (hemosiderin-like) iron: a biochemical validation in human liver explants. Proc. Int. Soc.Magn. Reson.Med. 18 (Abstract) In press.
34. Sheth, S., H. Tang, J.H. Jensen, et al. 2005. Methods for noninvasive measurement of tissue iron in Cooley's anemia. Ann. N.Y. Acad. Sci. 1054: 358-372.
35. Kim, D., J.H. Jensen, E.X. Wu, et al. 2009. Breathhold multiecho fast spin-echo pulse sequence for accurate R2 measurement in the heart and liver.Magn. Reson.Med. 62: 300-306.
36. Guo, H., W. Y. Au, J. S. Cheung, et al. 2009. Myocardial T2 quantitation in patients with iron overload at 3 Tesla. J. Magn. Reson. Imaging 30: 394-400.
37. Kim, D., J.H. Jensen, C. Tosti, et al. 2009. R2 imaging of ferritin iron in thalassemic patients off and on ironchelation therapy. Proc. Int. Soc.Magn. Reson.Med. 17: 3755 (Abstract).
38. Cheung, J.S., W.Y. Au, S.Y. Ha, et al. 2010. Monitoring iron chelation effect in hearts of thalassaemia patients with improved sensitivity using reduced transverse relaxation rate (RR2). Proc. Int. Soc. Magn. Reson. Med. 18: (Abstract) In press.